Israeli ophthalmic device company EyeYon Medical raises USD6.5 mn

 21-Mar-17, Globes 

Israeli ophthalmic device co EyeYon Medical has raised USD6.5 mn. The company has developed a special contact lens designed to treat corneal edema.

Image: Globes

The investment round was led by China-based venture capital fund Rimonci Capital and co-investor Gauss Group, as well existing investors Triventures and Pontifax, with a grant from Israel's Chief Scientist.

EyeYon Medical specializes in medical ophthalmic devices implementing promising, proprietary technologies that have proven feasibility to treat acute problems in the ophthalmic world. EyeYon’s platform consists of two main solutions: EndoArt®, an artificial endothelial layer which can replace the need for cadaver based implants and Hyper CLTM, a therapeutic soft contact lens.

 Read the full article  

 Insights